Press releases

2023

29 November 2023 Regulatory Scandion Oncology is granted new Composition of Matter-patent on lead compound SCO-101 extending its exclusivity until at least 2042 Download Presentation Webcast Workbook
22 November 2023 Regulatory Scandion Oncology – Interim Report Q3 2023 Download Presentation Webcast Workbook
21 November 2023 Regulatory Final data from the Phase IIa open-label CORIST part 2 trial shows impressive median Overall Survival of 10.4 months Download Presentation Webcast Workbook
15 November 2023 Regulatory Invitation to Scandion Oncology webcast and conference call November 22, 2023 Download Presentation Webcast Workbook
16 October 2023 Regulatory Phase Ib PANTAX trial is successfully completed and establishes the maximal tolerated dose with positive safety profile and pharmacokinetic data. Download Presentation Webcast Workbook
12 September 2023 Regulatory Scandion Oncology appoints Lars Damstrup, MD, PhD, as new Chief Medical Officer Download Presentation Webcast Workbook
23 August 2023 Regulatory Scandion Oncology – Interim Report Q2 2023 Download Presentation Webcast Workbook
17 August 2023 Regulatory Data from PANTAX trial to be presented at ESMO Congress 2023 Download Presentation Webcast Workbook
16 August 2023 Regulatory Invitation to Scandion Oncology webcast and conference call August 23, 2023 Download Presentation Webcast Workbook
18 July 2023 Regulatory The European Patent Office announces intention to grant of Composition-of-Matter patent for Scandion Oncology’s lead compound SCO-101 Download Presentation Webcast Workbook
26 May 2023 Regulatory Scandion Oncology – Interim Report Q1 2023 Download Presentation Webcast Workbook
19 May 2023 Invitation to Scandion Oncology webcast and conference call May 26, 2023 Download Presentation Webcast Workbook
26 April 2023 Regulatory Scandion Oncology Announces Results of Annual General Meeting and Constitution of the Board of Directors Download Presentation Webcast Workbook
11 April 2023 Regulatory Scandion Oncology – Notice convening the Annual General Meeting Download Presentation Webcast Workbook
31 March 2023 Regulatory Scandion Oncology successfully completes the dose finding with lead compound SCO-101 in advanced pancreatic cancer patients (PANTAX phase Ib trial) Download Presentation Webcast Workbook
28 March 2023 Regulatory Scandion Oncology – Annual Report 2022 Download Presentation Webcast Workbook
21 March 2023 Invitation to Scandion Oncology webcast and conference call March 28, 2023 Download Presentation Webcast Workbook
22 February 2023 Regulatory Scandion Oncology – Q4 & year-end report 2022 Download Presentation Webcast Workbook
15 February 2023 Invitation to Scandion Oncology webcast and conference call February 22, 2023 Download Presentation Webcast Workbook
19 January 2023 Regulatory Scandion Oncology A/S: Scandion Oncology receives favorable opinion from the European Patent Office on Composition of Matter Patent-application for lead compound SCO-101 Download Presentation Webcast Workbook
18 January 2023 Scandion Oncology A/S: Scandion Oncology appoints Jan Stenvang, Ph.D., Chief Scientific Officer and member of Executive Management Download Presentation Webcast Workbook

2022

5 December 2022 Scandion Oncology announces share purchase by incoming President & CEO Download Presentation Webcast Workbook
1 December 2022 Regulatory Scandion Oncology appoints Francois Martelet, M.D., as new Chief Executive Officer Download Presentation Webcast Workbook
23 November 2022 Scandion Oncology announces share purchase by member of the Board of Directors Download Presentation Webcast Workbook
16 November 2022 Regulatory Interim Report 1 July – 30 September 2022 Download Presentation Webcast Workbook
10 November 2022 Invitation to Scandion Oncology webcast and conference call November 16, 2022 Download Presentation Webcast Workbook
28 October 2022 Regulatory Scandion Oncology Announces Results of Extraordinary General Meeting Download Presentation Webcast Workbook
13 October 2022 Regulatory Scandion Oncology – Notice convening an Extraordinary General Meeting Download Presentation Webcast Workbook
10 October 2022 Scandion Oncology initiates part 3 of the CORIST phase II trial Download Presentation Webcast Workbook
30 September 2022 Regulatory Scandion Oncology announce topline results from part 2 of the CORIST phase II trial Download Presentation Webcast Workbook
31 August 2022 Regulatory Bo Rode Hansen is leaving the position as President and CEO of Scandion Oncology Download Presentation Webcast Workbook
30 August 2022 Regulatory Scandion Oncology announce change to its Executive Management Download Presentation Webcast Workbook
25 August 2022 Regulatory Scandion Oncology – Interim Report Q2 2022 Download Presentation Webcast Workbook
19 August 2022 Scandion Oncology receives approvals for next parts of the CORIST trial Download Presentation Webcast Workbook
18 August 2022 Invitation to Scandion Oncology webcast and conference call August 25, 2022 Download Presentation Webcast Workbook
17 August 2022 Regulatory Scandion Oncology extends PANTAX trial due to better-than-expected tolerability of SCO-101 Download Presentation Webcast Workbook
8 August 2022 Scandion Oncology announces share purchase by Board of Directors Download Presentation Webcast Workbook
26 July 2022 Scandion Oncology’s rights issue registered with the Danish Business Authority Download Presentation Webcast Workbook
4 July 2022 Scandion Oncology announces final outcome of its rights issue Download Presentation Webcast Workbook
1 July 2022 Regulatory Scandion Oncology announces preliminary outcome of its rights issue Download Presentation Webcast Workbook
16 June 2022 Subscription period in Scandion Oncology Rights Issue of up to approximately SEK 93.7 million commences Download Presentation Webcast Workbook
15 June 2022 Scandion Oncology publishes prospectus in connection with the rights issue of up to approximately SEK 93.7 million Download Presentation Webcast Workbook
3 June 2022 Invitation to Scandion Oncology webcast and conference call June 10, 2022 Download Presentation Webcast Workbook
1 June 2022 Regulatory Scandion Oncology resolves on a Rights Issue of approximately SEK 93.7 million Download Presentation Webcast Workbook
25 May 2022 Scandion Oncology announces change to its Board of Directors Download Presentation Webcast Workbook
19 May 2022 Regulatory Interim Report 1 January – 31 March 2022 Download Presentation Webcast Workbook
16 May 2022 Invitation to Scandion Oncology webcast and conference call May 19, 2022 Download Presentation Webcast Workbook
11 May 2022 Scandion Oncology enhances management and clinical development function with appointment of global executive as Chief Medical Officer Download Presentation Webcast Workbook
27 April 2022 Regulatory Scandion Oncology Announces Results of Annual General Meeting and Constitution of the Board of Directors Download Presentation Webcast Workbook
12 April 2022 Regulatory Scandion Oncology – Notice convening of Annual General Meeting Download Presentation Webcast Workbook
24 March 2022 Regulatory Scandion Oncology – Annual Report 2021 Download Presentation Webcast Workbook
17 February 2022 Regulatory Scandion Oncology announces its results for the fourth quarter and year-end 2021 Download Presentation Webcast Workbook
10 February 2022 Invitation to Scandion Oncology webcast and conference call February 17, 2022 Download Presentation Webcast Workbook
4 February 2022 Scandion Oncology announces share purchase by member of management Download Presentation Webcast Workbook
2 February 2022 Scandion Oncology expands clinical development with internationalization of the CORIST-trial Download Presentation Webcast Workbook
19 January 2022 Scandion Oncology announces share trade by a member of the Board of Directors to a closely associated person hereof Download Presentation Webcast Workbook
18 January 2022 Data from CORIST-trial to be presented at ASCO Gastrointestinal Cancers Symposium Download Presentation Webcast Workbook
12 January 2022 Scandion Oncology enhances its external communication Download Presentation Webcast Workbook

2021

2 December 2021 Scandion Oncology announces share purchase by a member of the Board of Directors Download Presentation Webcast Workbook
1 December 2021 Regulatory Scandion Oncology announce minutes of Extraordinary General Meeting Download Presentation Webcast Workbook
22 November 2021 Scandion Oncology announces share purchase by Board of Directors and Executive Management Download Presentation Webcast Workbook
18 November 2021 Regulatory Interim Report 1 July – 30 September 2021 Download Presentation Webcast Workbook
17 November 2021 Regulatory Scandion Oncology announce notice convening an Extraordinary General Meeting Download Presentation Webcast Workbook
15 November 2021 Invitation to Scandion Oncology A/S webcast and conference call November 18, 2021 Download Presentation Webcast Workbook
12 November 2021 Regulatory Scandion Oncology announce cancellation of extraordinary general meeting Download Presentation Webcast Workbook
8 November 2021 Regulatory PANTAX study read-out postponed Download Presentation Webcast Workbook
2 November 2021 Regulatory Scandion Oncology A/S: Notice convening an Extraordinary General Meeting Download Presentation Webcast Workbook
11 October 2021 Scandion Oncology A/S: Postponement of extraordinary general meeting Download Presentation Webcast Workbook
4 October 2021 Regulatory Scandion Oncology A/S: Cancellation of extraordinary general meeting Download Presentation Webcast Workbook
21 September 2021 Regulatory Scandion Oncology A/S: Notice convening an Extraordinary General Meeting Download Presentation Webcast Workbook
8 September 2021 Regulatory Scandion Oncology provides a clear path to market for SCO-101 at today’s Capital Markets Day Download Presentation Webcast Workbook
7 September 2021 Regulatory Scandion Oncology strengthens its Clinical Advisory Board with three new members Download Presentation Webcast Workbook
6 September 2021 Regulatory Scandion Oncology receives approval for initiating the CORIST part 2 trial Download Presentation Webcast Workbook
2 September 2021 Regulatory Positive Results from the Scandion Oncology A/S and Alligator Bioscience AB Collaboration Further Supports Efficacy of SCO-101 in Combination Therapy Download Presentation Webcast Workbook
27 August 2021 Scandion Oncology receives German trial approval for PANTAX Ib study Download Presentation Webcast Workbook
25 August 2021 Regulatory First US patent granted to Scandion Oncology on combination treatment with its candidate drug SCO-101 Download Presentation Webcast Workbook
19 August 2021 Regulatory Interim Report 1 April – 30 June 2021 Download Presentation Webcast Workbook
12 August 2021 Invitation to Scandion Oncology A/S webcast and conference call 19 August 2021 Download Presentation Webcast Workbook
19 July 2021 Scandion Oncology announces that its President & CEO has bought 4,500 shares in Scandion Oncology Download Presentation Webcast Workbook
19 July 2021 Save the date for the Scandion Oncology Capital Markets Day on September 8, 2021 Download Presentation Webcast Workbook
30 June 2021 Scandion Oncology A/S and Alligator Bioscience AB present promising preclinical data Download Presentation Webcast Workbook
24 June 2021 Regulatory Scandion Oncology reports positive interim results from the CORIST Phase II study Download Presentation Webcast Workbook
2 June 2021 Scandion Oncology appoints Johnny Stilou as new CFO Download Presentation Webcast Workbook
26 May 2021 Regulatory Scandion Oncology A/S: Minutes of the Annual General Meeting 2021 Download Presentation Webcast Workbook
20 May 2021 Regulatory Interim Report 1 April – 30 June 2021 Download Presentation Webcast Workbook
10 May 2021 Regulatory Scandion Oncology A/S: Notice convening the Annual General Meeting 2021 Download Presentation Webcast Workbook
29 April 2021 Regulatory Annual Report 2020: Scandion Oncology is setting the pace for the future Download Presentation Webcast Workbook
21 April 2021 Scandion Oncology engages former ASCO executive as clinical advisor Download Presentation Webcast Workbook
24 March 2021 CSO Nils Brünner will retire from Scandion Oncology A/S Download Presentation Webcast Workbook
19 March 2021 Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of R&D Operations Download Presentation Webcast Workbook
18 February 2021 Regulatory Year-end Report 2020: Scandion Oncology is poised for the future Download Presentation Webcast Workbook
28 January 2021 Regulatory Scandion Oncology adjusts the PANTAX pancreatic cancer study Download Presentation Webcast Workbook
23 January 2021 Regulatory Scandion Oncology has finalized the first 12 patients in the CORIST study Download Presentation Webcast Workbook
19 January 2021 Scandion Oncology approved for listing on Nasdaq First North Growth Market Sweden on 3 February 2021 Download Presentation Webcast Workbook
6 January 2021 Scandion Oncology’s rights issue registered with the Danish Business Authority – BTAs are converted to shares Download Presentation Webcast Workbook

2020

18 December 2020 Letter from the CEO: Great progress in 2020 – we are ready for 2021! Download Presentation Webcast Workbook
16 December 2020 Scandion Oncology A/S – Flagging message Download Presentation Webcast Workbook
15 December 2020 Scandion Oncology: Supplement to previously published press release regarding the outcome of Scandion Oncology’s rights issue Download Presentation Webcast Workbook
15 December 2020 Regulatory SCANDION ONCOLOGY ANNOUNCES OUTCOME IN THE RIGHTS ISSUE Download Presentation Webcast Workbook
24 November 2020 Scandion Oncology publishes prospectus relating to the rights issue and announces the intention of changing listing venue to Nasdaq First North Growth Market Sweden Download Presentation Webcast Workbook
19 November 2020 Regulatory Interim Report 1 January 2020 – 30 September 2020 Download Presentation Webcast Workbook
17 November 2020 Correction of previously published press release regarding Scandion Oncology’s rights issue (trading in BTAs) Download Presentation Webcast Workbook
16 November 2020 Regulatory The Board of Directors of Scandion Oncology has resolved on a fully guaranteed rights issue of approximately SEK 236 million Download Presentation Webcast Workbook
13 November 2020 Regulatory Correction: Scandion Oncology – Minutes of extraordinary general meeting Download Presentation Webcast Workbook
13 November 2020 Regulatory Scandion Oncology – Minutes of extraordinary general meeting Download Presentation Webcast Workbook
28 October 2020 Regulatory Scandion Oncology: Notice to convene Extraordinary General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
28 October 2020 Regulatory Scandion Oncology A/S initiates its second clinical study with SCO-101 Download Presentation Webcast Workbook
9 October 2020 Scandion Oncology announces that the warrant exercise is registered at the Danish Companies Registration Office Download Presentation Webcast Workbook
7 October 2020 Regulatory Scandion Oncology announces modified timelines for clinical studies Download Presentation Webcast Workbook
6 October 2020 Regulatory Scandion Oncology receives approximately MSEK 12.3 through successful warrant exercise Download Presentation Webcast Workbook
3 October 2020 Regulatory Scandion Oncology announces that it has been selected for the final round of MATWIN presentations Download Presentation Webcast Workbook
2 October 2020 Regulatory Communique from the Extraordinary General Meeting of Scandion Oncology A/S Download Presentation Webcast Workbook
29 September 2020 Scandion Oncology’s management and Board of Directors have exercised their Scandion Oncology A/S series TO 1 warrants Download Presentation Webcast Workbook
28 September 2020 Regulatory Scandion Oncology receives final approval from the Danish Medicines Agency and Ethical Committee for start of a clinical trial in patients with pancreatic cancer Download Presentation Webcast Workbook
25 September 2020 Reminder to exercise Scandion Oncology A/S series TO 1 warrants Download Presentation Webcast Workbook
16 September 2020 Regulatory Notice to Extraordinary General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
16 September 2020 Regulatory Scandion Oncology strengthens executive leadership appointing Bo Rode Hansen as CEO and Nils Brünner as new CSO Download Presentation Webcast Workbook
10 September 2020 The exercise period for warrants in Scandion Oncology A/S begins today Download Presentation Webcast Workbook
20 August 2020 Regulatory Scandion Oncology announces results from the next evaluable chemo-resistant colorectal cancer patient treated with SCO-101 and chemotherapy Download Presentation Webcast Workbook
20 August 2020 Regulatory Half-Year Report 1 January 2020 – 30 June 2020 Download Presentation Webcast Workbook
1 August 2020 Regulatory Scandion Oncology announces that one of its founders, Saniona, has reduced its shareholding to below 10% of the total share amount Download Presentation Webcast Workbook
31 July 2020 Regulatory Scandion Oncology drug SCO-101 potentiates the effect of chemotherapy in the first cohort of patients with chemo-resistant metastatic colorectal cancer Download Presentation Webcast Workbook
11 July 2020 Regulatory Scandion Oncology announces that the results of the 4 SCO-101 clinical phase I trials have been published in the journal “Basic & Clinical Pharmacology & Toxocology”. Download Presentation Webcast Workbook
3 July 2020 Regulatory Scandion Oncology announces that its Chairman of the Board has bought 6000 shares in Scandion Oncology Download Presentation Webcast Workbook
30 June 2020 Regulatory Scandion Oncology co-founders extend lock-up period Download Presentation Webcast Workbook
22 June 2020 Regulatory Scandion Oncology announces that one of its founders, Saniona, has reduced its shareholding to below 15% of the total share amount Download Presentation Webcast Workbook
16 June 2020 Regulatory Scandion Oncology has received a Eurostars grant of 800,000 EUR, shared with Erasmus Medical Centre, Rotterdam and 2cureX AB, for evaluating SCO-101 against antiestrogen resistance in breast cancer Download Presentation Webcast Workbook
9 June 2020 Regulatory Scandion Oncology announces that the Clinical Trial Application for a pancreatic cancer study with chemotherapy and SCO-101 has been submitted to the Danish Medicines Agency and the Ethical Committee. Download Presentation Webcast Workbook
4 June 2020 Regulatory Alligator Bioscience and Scandion Oncology sign preclinical agreement to explore combination therapies for chemotherapy and immuno-oncology Download Presentation Webcast Workbook
27 May 2020 Regulatory Scandion Oncology announces that the first patient has received treatment with SCO-101 in combination with FOLFIRI. Download Presentation Webcast Workbook
21 May 2020 Regulatory Interim report 1 January – 31 March 2020 Download Presentation Webcast Workbook
15 May 2020 Regulatory Scandion Oncology’s drug SOM-001 demonstrates antibiotic activity in a mouse model infected with MRSA bacteria Download Presentation Webcast Workbook
11 May 2020 Regulatory Notice to Annual General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
30 April 2020 Regulatory Scandion Oncology A/S Annual Report 2019 published Download Presentation Webcast Workbook
24 April 2020 Presentation of the ongoing Clinical Phase II trial at the AACR Virtual Annual Meeting Download Presentation Webcast Workbook
26 March 2020 Scandion Oncology CEO Newsletter (March 2020) Download Presentation Webcast Workbook
25 March 2020 Regulatory SCO-101 works in synergy with the chemotherapy drug docetaxel in drug resistant cancer cells Download Presentation Webcast Workbook
23 March 2020 Regulatory Clinical development plans for SCO-101 Download Presentation Webcast Workbook
20 March 2020 Regulatory Short delay of the antibiotic resistance data Download Presentation Webcast Workbook
10 March 2020 Chairman, Vice-Chairman and CMO in Scandion Oncology A/S buy Company shares Download Presentation Webcast Workbook
9 March 2020 Regulatory Short delay in the clinical phase II study Download Presentation Webcast Workbook
6 March 2020 Publication on pre-clinical results with SCO-201 Download Presentation Webcast Workbook
20 February 2020 Regulatory Year-end Report 1 January – 31 December 2019 Download Presentation Webcast Workbook
19 February 2020 Regulatory Scandion Oncology receives DKK 5 million in soft money from Innovation Fund Denmark Download Presentation Webcast Workbook
3 February 2020 Regulatory Correction of dates for public information on Estimated Primary Completion and Primary Study Completion for a Clinical Phase II study Download Presentation Webcast Workbook
27 January 2020 Scandion Oncology Newsletter 27 January, 2020 Download Presentation Webcast Workbook
21 January 2020 Scandion Oncology Newsletter 21st January, 2020 Download Presentation Webcast Workbook
14 January 2020 Scandion Oncology News, January 2020 Download Presentation Webcast Workbook
13 January 2020 Scandion Oncology to attend the JP Morgan 38th Annual Healthcare Conference Download Presentation Webcast Workbook

2019

23 December 2019 Regulatory Scandion Oncology obtains approval from the Ethics Committee on Clinical Application for SCO-101 in patients with drug-resistant metastatic colorectal cancer Download Presentation Webcast Workbook
16 December 2019 Regulatory Anti-bacterial treatment: Novel analogues with more than tenfold higher potency identified and technical issues with the in vivo experiments Download Presentation Webcast Workbook
29 November 2019 Regulatory Chairman and Vice-Chairman of the Board in Scandion Oncology A/S buy Company shares Download Presentation Webcast Workbook
29 November 2019 Regulatory Scandion Oncology receives final approval from the Danish Medicines Agency for start of clinical Phase II trial in patients with drug resistant metastatic colorectal cancer Download Presentation Webcast Workbook
21 November 2019 Scandion Oncology CEO Newsletter November 2019 Download Presentation Webcast Workbook
21 November 2019 Regulatory Interim Report 1 January 2019 – 30 September 2019 Download Presentation Webcast Workbook
14 October 2019 Regulatory Scandion Oncology A/S receives EU-patent for SCO-101 Download Presentation Webcast Workbook
1 October 2019 Regulatory Scandion Oncology applies for start of clinical Phase II trial in patients with metastatic colorectal cancer Download Presentation Webcast Workbook
1 October 2019 Regulatory In vivo animal data report on antibiotic resistance extended until mid-Q4 2019 Download Presentation Webcast Workbook
1 October 2019 Regulatory Peter Høngaard new Chairman of the Board in Scandion Oncology Download Presentation Webcast Workbook
24 September 2019 Scandion Oncology CEO Newsletter autumn 2019 Download Presentation Webcast Workbook
29 August 2019 Flagging notification in Scandion Oncology A/S Download Presentation Webcast Workbook
22 August 2019 Regulatory Interim Report 1 January – 30 June 2019 Download Presentation Webcast Workbook
21 August 2019 Update on Q & A Download Presentation Webcast Workbook
5 August 2019 First day of trading in TO 1 in Scandion Oncology Download Presentation Webcast Workbook
25 July 2019 Last day of trading in BTU in Scandion Oncology Download Presentation Webcast Workbook
12 July 2019 Regulatory Significantly oversubscribed rights issue in Scandion Oncology Download Presentation Webcast Workbook
27 June 2019 Scandion Oncology has identified four clinical sites to take part in the planned Phase II clinical trial Download Presentation Webcast Workbook
26 June 2019 SCO-101 is successfully produced as tablets Download Presentation Webcast Workbook
20 June 2019 The subscription period in Scandion Oncology’s rights issue begins today Download Presentation Webcast Workbook
17 June 2019 Regulatory Scandion Oncology A/S publishes prospectus in connection with rights issue Download Presentation Webcast Workbook
11 June 2019 Regulatory Communique from the Extraordinary General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
6 June 2019 Scandion Oncology appoints Chairman and Vice-Chairman of its Board of Directors Download Presentation Webcast Workbook
31 May 2019 Regulatory Communique from the Annual General Meeting of Scandion Oncology A/S Download Presentation Webcast Workbook
27 May 2019 Regulatory Notice of Extraordinary General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
27 May 2019 Regulatory The board of Scandion Oncology proposes a rights issue to increase the commercial potential for its drug candidates and to expand its drug pipeline Download Presentation Webcast Workbook
27 May 2019 Regulatory Interim report 1 January – 31 March 2019 Download Presentation Webcast Workbook
21 May 2019 Scandion Oncology A/S announces new date for publication of interim report January – March 2019 Download Presentation Webcast Workbook
21 May 2019 Regulatory SCANDION ONCOLOGY A/S obtains “Intention to Grant” notice for SCO-101 from the European Patent Office (EPO) Download Presentation Webcast Workbook
14 May 2019 Regulatory Notice to Annual General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
3 May 2019 Regulatory Scandion Oncology A/S Annual Report 2018 published Download Presentation Webcast Workbook
16 April 2019 Regulatory Scandion Oncology signs collaboration agreement with University of Copenhagen regarding co-development of a class of drug candidates that reverts anti-cancer drug resistance Download Presentation Webcast Workbook
8 April 2019 Regulatory Scandion Oncology obtains EU Funding for SCO-101 in drug resistant breast cancer patients Download Presentation Webcast Workbook
26 March 2019 Regulatory Scandion Oncology A/S reports successful meeting with Danish Medicines Agency regarding clinical development of SCO-101 Download Presentation Webcast Workbook
18 March 2019 Scandion Oncology Signs Contract with Solural Pharma to Formulate SCO-101 Tablets for Clinical Phase II Trial Download Presentation Webcast Workbook
11 March 2019 Scandion Oncology A/S Obtains Positive Preclinical Results in Antibiotic Resistance Download Presentation Webcast Workbook
21 February 2019 Regulatory Year-end Report 1 January – 31 December 2018 Download Presentation Webcast Workbook

2018

21 December 2018 Senior executives increase their holdings in Scandion Oncology A/S Download Presentation Webcast Workbook
14 December 2018 Scandion Oncology informs on the selection of collaborator for the Boost4Health Internationalisation grant Download Presentation Webcast Workbook
22 November 2018 Regulatory Interim Report 1 January – 30 September 2018 Download Presentation Webcast Workbook
13 November 2018 Scandion Oncology to receive EU support to boost international development Download Presentation Webcast Workbook
4 October 2018 The subscription period for Scandion Oncology A/S new share issue begins today Download Presentation Webcast Workbook
1 October 2018 Scandion Oncology A/S approved for listing at Spotlight Stock Market Download Presentation Webcast Workbook